Pub Date : 2024-10-09DOI: 10.1016/s2215-0366(24)00315-8
Natalia E Fares-Otero, Ingo Schäfer, Eduard Vieta, Soraya Seedat, Sarah L Halligan
No Abstract
无摘要
{"title":"Fathers who experienced childhood maltreatment: aggression and testosterone","authors":"Natalia E Fares-Otero, Ingo Schäfer, Eduard Vieta, Soraya Seedat, Sarah L Halligan","doi":"10.1016/s2215-0366(24)00315-8","DOIUrl":"https://doi.org/10.1016/s2215-0366(24)00315-8","url":null,"abstract":"No Abstract","PeriodicalId":48784,"journal":{"name":"Lancet Psychiatry","volume":"68 1","pages":""},"PeriodicalIF":64.3,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142386249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-08DOI: 10.1016/s2215-0366(24)00286-4
Karen Herrera-Ferrá, José M Muñoz, Anahiby Becerril, Eric García-López, José Ángel Marinaro, Luis Ricardo Sánchez Hernández, Jesús Alejandro Alonso Otamendi, Alejandra Lagunes Soto Ruiz
No Abstract
无摘要
{"title":"The regulation of neurotechnology: the neurorights bill in Mexico","authors":"Karen Herrera-Ferrá, José M Muñoz, Anahiby Becerril, Eric García-López, José Ángel Marinaro, Luis Ricardo Sánchez Hernández, Jesús Alejandro Alonso Otamendi, Alejandra Lagunes Soto Ruiz","doi":"10.1016/s2215-0366(24)00286-4","DOIUrl":"https://doi.org/10.1016/s2215-0366(24)00286-4","url":null,"abstract":"No Abstract","PeriodicalId":48784,"journal":{"name":"Lancet Psychiatry","volume":"78 1","pages":""},"PeriodicalIF":64.3,"publicationDate":"2024-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142385060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-04DOI: 10.1016/s2215-0366(24)00319-5
No Abstract
无摘要
{"title":"Ukraine is not alone","authors":"","doi":"10.1016/s2215-0366(24)00319-5","DOIUrl":"https://doi.org/10.1016/s2215-0366(24)00319-5","url":null,"abstract":"No Abstract","PeriodicalId":48784,"journal":{"name":"Lancet Psychiatry","volume":"5 1","pages":""},"PeriodicalIF":64.3,"publicationDate":"2024-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142374602","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-04DOI: 10.1016/s2215-0366(24)00241-4
Irina Pinchuk, Bennett L Leventhal, Alisa Ladyk-Bryzghalova, Lars Lien, Yuliia Yachnik, Marisa Casanova Dias, Volodymyr Virchenko, Peter Szatmari, Olena Protsenko, Gary Andrew Chaimowitz, Dan Chisholm, Viktoriia Kolokolova, Anthony P S Guerrero, Stanislav Chumak, Olha Myshakivska, Paul Gerard Robertson, Mark D Hanson, Howard Yee Liu, Livia Joanna De Picker, Marina Kupchik, Norbert Skokauskas
<h2>Section snippets</h2><section><section><h2>Executive summary</h2>The Russian invasion and annexation of eastern Ukraine and Crimea in 2014, along with the ongoing war since February, 2022, have inflicted incalculable damage to Ukraine with many deaths and injuries, massive population displacement, and extensive physical and emotional trauma. These events put an immense strain on the general health-care and mental health-care systems. For many years the mental health-care system in Ukraine was dominated by large psychiatric hospitals and residential</section></section><section><section><h2>Introduction: History and vision for change</h2>Ukraine, the largest democratic country in Europe, has been faced with a perfect storm of challenges. From 1922 to 1991, it was part of the Soviet Union where the mental health-care system was dominated by large psychiatric hospitals and residential institutions focusing almost exclusively on biological therapies. The system was well known for neglect, abuses, and human rights violations.1, 2 As Ukraine emerged from the Soviet era into independence, it underwent massive political, economic, and</section></section><section><section><h2>Part 1: Community-based mental health care and a vision for a new network of Ukrainian mental health-care services</h2>The Commission developed a consensus that Ukraine should develop a network of community-based mental health-care services. A sequence of incremental steps of change should be designed to facilitate progression from the current system towards a community-based mental health-care system.Before 2017, the Ukrainian mental health-care system focused on treatment and tracking (called dispanserisation) of people with severe mental disorders. This strategy was delivered through a network of inpatient</section></section><section><section><h2>Part 2: Training and education of the mental health workforce</h2>A 21st century mental health-care system requires an enabled and skilled multidisciplinary workforce that meets the immediate and emerging needs of the settings in both primary care and specialist mental health-care systems. Nurses, psychologists, allied health professionals, family doctors, and specialists in psychiatry are the core of this mental health workforce. This diverse group requires broad, overlapping capabilities and discipline-specific competencies to function as an integrated and</section></section><section><section><h2>Part 3: Rebuilding mental health research capacity and infrastructure</h2>Historically, Soviet models have dominated Ukrainian mental health research, leaving the country lagging behind European, US, and other models. Since Ukraine gained independence, with the assistance of international colleagues, creative leaders in Ukrainian psychiatry have initiated efforts to remedy these problems. However, the Russian invasion of eastern Ukraine and Crimea in 2014, and the full-scale war in 2022, led to the massive destruction of Ukrainian universiti
{"title":"The Lancet Psychiatry Commission on mental health in Ukraine","authors":"Irina Pinchuk, Bennett L Leventhal, Alisa Ladyk-Bryzghalova, Lars Lien, Yuliia Yachnik, Marisa Casanova Dias, Volodymyr Virchenko, Peter Szatmari, Olena Protsenko, Gary Andrew Chaimowitz, Dan Chisholm, Viktoriia Kolokolova, Anthony P S Guerrero, Stanislav Chumak, Olha Myshakivska, Paul Gerard Robertson, Mark D Hanson, Howard Yee Liu, Livia Joanna De Picker, Marina Kupchik, Norbert Skokauskas","doi":"10.1016/s2215-0366(24)00241-4","DOIUrl":"https://doi.org/10.1016/s2215-0366(24)00241-4","url":null,"abstract":"<h2>Section snippets</h2><section><section><h2>Executive summary</h2>The Russian invasion and annexation of eastern Ukraine and Crimea in 2014, along with the ongoing war since February, 2022, have inflicted incalculable damage to Ukraine with many deaths and injuries, massive population displacement, and extensive physical and emotional trauma. These events put an immense strain on the general health-care and mental health-care systems. For many years the mental health-care system in Ukraine was dominated by large psychiatric hospitals and residential</section></section><section><section><h2>Introduction: History and vision for change</h2>Ukraine, the largest democratic country in Europe, has been faced with a perfect storm of challenges. From 1922 to 1991, it was part of the Soviet Union where the mental health-care system was dominated by large psychiatric hospitals and residential institutions focusing almost exclusively on biological therapies. The system was well known for neglect, abuses, and human rights violations.1, 2 As Ukraine emerged from the Soviet era into independence, it underwent massive political, economic, and</section></section><section><section><h2>Part 1: Community-based mental health care and a vision for a new network of Ukrainian mental health-care services</h2>The Commission developed a consensus that Ukraine should develop a network of community-based mental health-care services. A sequence of incremental steps of change should be designed to facilitate progression from the current system towards a community-based mental health-care system.Before 2017, the Ukrainian mental health-care system focused on treatment and tracking (called dispanserisation) of people with severe mental disorders. This strategy was delivered through a network of inpatient</section></section><section><section><h2>Part 2: Training and education of the mental health workforce</h2>A 21st century mental health-care system requires an enabled and skilled multidisciplinary workforce that meets the immediate and emerging needs of the settings in both primary care and specialist mental health-care systems. Nurses, psychologists, allied health professionals, family doctors, and specialists in psychiatry are the core of this mental health workforce. This diverse group requires broad, overlapping capabilities and discipline-specific competencies to function as an integrated and</section></section><section><section><h2>Part 3: Rebuilding mental health research capacity and infrastructure</h2>Historically, Soviet models have dominated Ukrainian mental health research, leaving the country lagging behind European, US, and other models. Since Ukraine gained independence, with the assistance of international colleagues, creative leaders in Ukrainian psychiatry have initiated efforts to remedy these problems. However, the Russian invasion of eastern Ukraine and Crimea in 2014, and the full-scale war in 2022, led to the massive destruction of Ukrainian universiti","PeriodicalId":48784,"journal":{"name":"Lancet Psychiatry","volume":"57 1","pages":""},"PeriodicalIF":64.3,"publicationDate":"2024-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142374600","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-04DOI: 10.1016/s2215-0366(24)00289-x
Matthew Menear
No Abstract
无摘要
{"title":"Building a recovery-oriented mental health system in Ukraine: lessons from implementation science","authors":"Matthew Menear","doi":"10.1016/s2215-0366(24)00289-x","DOIUrl":"https://doi.org/10.1016/s2215-0366(24)00289-x","url":null,"abstract":"No Abstract","PeriodicalId":48784,"journal":{"name":"Lancet Psychiatry","volume":"4 1","pages":""},"PeriodicalIF":64.3,"publicationDate":"2024-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142374603","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-04DOI: 10.1016/s2215-0366(24)00325-0
Orest Suvalo, Vsevolod Borovets
No Abstract
无摘要
{"title":"Ukrainian mental health in transition: from totalitarianism towards a modern mental health system","authors":"Orest Suvalo, Vsevolod Borovets","doi":"10.1016/s2215-0366(24)00325-0","DOIUrl":"https://doi.org/10.1016/s2215-0366(24)00325-0","url":null,"abstract":"No Abstract","PeriodicalId":48784,"journal":{"name":"Lancet Psychiatry","volume":"78 1","pages":""},"PeriodicalIF":64.3,"publicationDate":"2024-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142374598","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-04DOI: 10.1016/s2215-0366(24)00312-2
Kostyantyn Dumchev, Vitalii Klymchuk
No Abstract
无摘要
{"title":"The Commission on mental health in Ukraine: areas for development","authors":"Kostyantyn Dumchev, Vitalii Klymchuk","doi":"10.1016/s2215-0366(24)00312-2","DOIUrl":"https://doi.org/10.1016/s2215-0366(24)00312-2","url":null,"abstract":"No Abstract","PeriodicalId":48784,"journal":{"name":"Lancet Psychiatry","volume":"1 1","pages":""},"PeriodicalIF":64.3,"publicationDate":"2024-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142374601","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-01Epub Date: 2024-09-03DOI: 10.1016/S2215-0366(24)00245-1
Hao Luo, Yi Chai, Sijia Li, Wallis C Y Lau, Carmen Olga Torre, Joseph Hayes, Ivan C H Lam, Xiaoyu Lin, Can Yin, Stephen Fortin, Dave M Kern, Dong Yun Lee, Rae Woong Park, Jae-Won Jang, Celine S L Chui, Jing Li, Sarah Seager, Kenneth K C Man, Ian C K Wong
Background: People with mental health conditions were potentially more vulnerable than others to the neuropsychiatric effects of the COVID-19 pandemic and the global efforts taken to contain it. The aim of this multinational study was to examine the changes in psychotropic drug prescribing during the pandemic among people with depressive and anxiety disorders.
Methods: This study included electronic medical records and claims data from nine databases in six countries (France, Germany, Italy, the UK, South Korea, and the USA) of patients with a diagnosis of depressive or anxiety disorders between 2016 and 2021. The outcomes were monthly prevalence rates of antidepressant, antipsychotic, and anxiolytic drug prescribing. The associations between the pandemic and psychotropic drug prescribing were examined with interrupted time series analyses for the total sample and stratified by sex and age group. People with lived experience were not involved in the research and writing process.
Findings: Between Jan 1, 2016 and Dec 31, 2020, an average of 16 567 914 patients with depressive disorders (10 820 956 females [65·31%] and 5 746 958 males [34·69%]) and 15 988 451 patients with anxiety disorders (10 688 788 females [66·85%] and 5 299 663 males [33·15%]) were identified annually. Most patients with depressive disorders and anxiety disorders were aged 45-64 years. Ethnicity data were not available. Two distinct trends in prescribing rates were identified. The first pattern shows an initial surge at the start of the pandemic (eg, antipsychotics among patients with depressive disorders in MDCD_US (rate ratio [RR] 1·077, 95% CI 1·055-1·100), followed by a gradual decline towards the counterfactual level (RR 0·990, 95% CI 0·988-0·992). The second pattern, observed in four databases for anxiolytics among patients with depressive disorders and two for antipsychotics among patients with anxiety disorders, shows an immediate increase (eg, antipsychotics among patients with anxiety disorders in IQVIA_UK: RR 1·467, 95% CI 1·282-1·675) without a subsequent change in slope (RR 0·985, 95% CI 0·969-1·003). In MDCD_US and IQVIA_US, the anxiolytic prescribing rate continued to increase among patients younger than 25 years for both disorders.
Interpretation: The study reveals persistently elevated rates of psychotropic drug prescriptions beyond the initial phase of the pandemic. These findings underscore the importance of enhanced mental health support and emphasise the need for regular review of psychotropic drug use among this patient group in the post-pandemic era.
Funding: University Grants Committee, Research Grants Council, The Government of the Hong Kong Special Administrative Region.
{"title":"Psychotropic drug prescribing before and during the COVID-19 pandemic among people with depressive and anxiety disorders: a multinational network study.","authors":"Hao Luo, Yi Chai, Sijia Li, Wallis C Y Lau, Carmen Olga Torre, Joseph Hayes, Ivan C H Lam, Xiaoyu Lin, Can Yin, Stephen Fortin, Dave M Kern, Dong Yun Lee, Rae Woong Park, Jae-Won Jang, Celine S L Chui, Jing Li, Sarah Seager, Kenneth K C Man, Ian C K Wong","doi":"10.1016/S2215-0366(24)00245-1","DOIUrl":"10.1016/S2215-0366(24)00245-1","url":null,"abstract":"<p><strong>Background: </strong>People with mental health conditions were potentially more vulnerable than others to the neuropsychiatric effects of the COVID-19 pandemic and the global efforts taken to contain it. The aim of this multinational study was to examine the changes in psychotropic drug prescribing during the pandemic among people with depressive and anxiety disorders.</p><p><strong>Methods: </strong>This study included electronic medical records and claims data from nine databases in six countries (France, Germany, Italy, the UK, South Korea, and the USA) of patients with a diagnosis of depressive or anxiety disorders between 2016 and 2021. The outcomes were monthly prevalence rates of antidepressant, antipsychotic, and anxiolytic drug prescribing. The associations between the pandemic and psychotropic drug prescribing were examined with interrupted time series analyses for the total sample and stratified by sex and age group. People with lived experience were not involved in the research and writing process.</p><p><strong>Findings: </strong>Between Jan 1, 2016 and Dec 31, 2020, an average of 16 567 914 patients with depressive disorders (10 820 956 females [65·31%] and 5 746 958 males [34·69%]) and 15 988 451 patients with anxiety disorders (10 688 788 females [66·85%] and 5 299 663 males [33·15%]) were identified annually. Most patients with depressive disorders and anxiety disorders were aged 45-64 years. Ethnicity data were not available. Two distinct trends in prescribing rates were identified. The first pattern shows an initial surge at the start of the pandemic (eg, antipsychotics among patients with depressive disorders in MDCD_US (rate ratio [RR] 1·077, 95% CI 1·055-1·100), followed by a gradual decline towards the counterfactual level (RR 0·990, 95% CI 0·988-0·992). The second pattern, observed in four databases for anxiolytics among patients with depressive disorders and two for antipsychotics among patients with anxiety disorders, shows an immediate increase (eg, antipsychotics among patients with anxiety disorders in IQVIA_UK: RR 1·467, 95% CI 1·282-1·675) without a subsequent change in slope (RR 0·985, 95% CI 0·969-1·003). In MDCD_US and IQVIA_US, the anxiolytic prescribing rate continued to increase among patients younger than 25 years for both disorders.</p><p><strong>Interpretation: </strong>The study reveals persistently elevated rates of psychotropic drug prescriptions beyond the initial phase of the pandemic. These findings underscore the importance of enhanced mental health support and emphasise the need for regular review of psychotropic drug use among this patient group in the post-pandemic era.</p><p><strong>Funding: </strong>University Grants Committee, Research Grants Council, The Government of the Hong Kong Special Administrative Region.</p>","PeriodicalId":48784,"journal":{"name":"Lancet Psychiatry","volume":" ","pages":"807-817"},"PeriodicalIF":30.8,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142146617","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-01DOI: 10.1016/s2215-0366(24)00284-0
Jules Morgan
{"title":"Dr Alfiee: Transforming lives for people of colour.","authors":"Jules Morgan","doi":"10.1016/s2215-0366(24)00284-0","DOIUrl":"https://doi.org/10.1016/s2215-0366(24)00284-0","url":null,"abstract":"","PeriodicalId":48784,"journal":{"name":"Lancet Psychiatry","volume":"4 1","pages":"793"},"PeriodicalIF":64.3,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142273565","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：